Entity Common Stock, Shares Outstanding of Travere Therapeutics, Inc. from 31 Aug 2011 to 13 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Travere Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Aug 2011 to 13 Feb 2026.
  • Travere Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Feb 2026 was 92,241,550.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Travere Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 92,241,550 13 Feb 2026 10-K 19 Feb 2026 2025 FY
Q3 2025 89,472,327 +11,422,399 +15% 27 Oct 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 89,138,673 +12,647,188 +17% 31 Jul 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 88,804,818 +12,675,800 +17% 28 Apr 2025 10-Q 01 May 2025 2025 Q1
Q3 2024 78,049,928 +2,904,097 +3.9% 28 Oct 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 76,491,485 +1,480,620 +2% 29 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 76,129,018 +1,521,117 +2% 02 May 2024 10-Q 06 May 2024 2024 Q1
Q3 2023 75,145,831 +10,972,261 +17% 03 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 75,010,865 +11,052,966 +17% 01 Aug 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 74,607,901 +11,093,749 +17% 02 May 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 64,173,570 +2,947,178 +4.8% 25 Oct 2022 10-Q 27 Oct 2022 2022 Q3
Q2 2022 63,957,899 +3,240,723 +5.3% 02 Aug 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 63,514,152 +3,056,498 +5.1% 03 May 2022 10-Q 05 May 2022 2022 Q1
Q3 2021 61,226,392 +10,174,572 +20% 26 Oct 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 60,717,176 +9,811,253 +19% 27 Jul 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 60,457,654 +17,302,082 +40% 04 May 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 51,051,820 +8,093,419 +19% 03 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 50,905,923 +7,951,772 +19% 29 Jul 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 43,155,572 +1,742,737 +4.2% 07 May 2020 10-Q 11 May 2020 2020 Q1
Q3 2019 42,958,401 +1,710,792 +4.1% 29 Oct 2019 10-Q 30 Oct 2019 2019 Q3
Q2 2019 42,954,151 +2,527,422 +6.3% 05 Aug 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 41,412,835 +1,468,875 +3.7% 25 Feb 2019 10-K 26 Feb 2019 2018 FY
Q3 2018 41,247,609 +1,940,910 +4.9% 01 Nov 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 40,426,729 +2,041,263 +5.3% 01 Aug 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 39,943,960 +1,850,377 +4.9% 30 Apr 2018 10-Q 06 Jul 2018 2018 Q1
Q3 2017 39,306,699 +1,574,370 +4.2% 06 Nov 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 38,385,466 +1,654,334 +4.5% 08 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 38,093,583 +1,416,848 +3.9% 28 Feb 2017 10-K 01 Mar 2017 2016 FY
Q3 2016 37,732,329 +1,583,399 +4.4% 03 Nov 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 36,731,132 +1,658,375 +4.7% 04 Aug 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 36,676,735 +10,190,165 +38% 04 May 2016 10-Q 05 May 2016 2016 Q1
Q3 2015 36,148,930 +9,449,083 +35% 02 Nov 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 35,072,757 +8,391,243 +31% 30 Jun 2015 10-K/A 09 Jul 2015 2013 FY
Q1 2015 26,486,570 +2,223,854 +9.2% 03 Mar 2015 10-K 11 Mar 2015 2014 FY
Q3 2014 26,699,847 +8,549,010 +47% 12 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 26,681,514 +14,586,371 +121% 12 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 24,262,716 +12,195,534 +101% 19 Mar 2014 10-K 28 Mar 2014 2013 FY
Q3 2013 18,150,837 +18,044,143 +16912% 13 Sep 2013 10-Q 16 Sep 2013 2013 Q2
Q2 2013 12,095,143 +11,988,448 +11236% 18 Jul 2013 10-Q 24 Jul 2013 2013 Q1
Q1 2013 12,067,182 +11,960,501 +11211% 28 Feb 2013 10-Q 06 Mar 2013 2012 Q3
Q3 2012 106,694 -852,433 -89% 31 Aug 2012 10-Q 10 Oct 2012 2012 Q2
Q2 2012 106,695 31 May 2012 10-Q 08 Aug 2012 2012 Q1
Q1 2012 106,681 29 Feb 2012 10-K 24 May 2012 2011 FY
Q4 2011 959,127 30 Nov 2011 10-Q 11 Jan 2012 2011 Q3
Q3 2011 959,127 31 Aug 2011 10-Q/A 06 Jun 2012 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.